PFG Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,083
Closed -$37K 501
2021
Q4
$37K Buy
+10,083
New +$43.4K ﹤0.01% 523
2020
Q1
Sell
-12,850
Closed -$81K 317
2019
Q4
$81K Buy
12,850
+300
+2% +$1.69K 0.02% 293
2019
Q3
$72K Buy
12,550
+200
+2% +$1.36K 0.02% 300
2019
Q2
$94K Buy
12,350
+2,200
+22% +$11.8K 0.03% 306
2019
Q1
$44K Buy
+10,150
New +$70.4K 0.01% 289

Other funds holding PGEN

PFG Advisors's PGEN Position: Q1 2022 in Review

PFG Advisors sold out of Precigen (PGEN) in Q1 2022, closing a stake of 10,083 shares — an estimated $37K sold.

PFG Advisors first reported a position in PGEN in Q1 2019 and held it in 5 quarters. The position peaked at $94K in Q2 2019. 173 funds tracked by Wall St. Rank hold PGEN as of Q1 2022.

  • PFG Advisors reported no remaining Precigen position as of Q1 2022 after selling out during the quarter.
  • PFG Advisors sold 10,083 Precigen shares in Q1 2022, an estimated $37K.
  • PFG Advisors first reported a position in Precigen in Q1 2019 and held it in 5 quarters.
  • PFG Advisors's Precigen position peaked at $94K in Q2 2019.
  • 173 funds tracked by Wall St. Rank held Precigen as of Q1 2022.

Based on PFG Advisors's 13F filing for Q1 2022, filed 19 Apr 2022.